Mesoblast Limited ( MEOBF) - Key Metrics
MEOBF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | ? | ? | ? | ? |
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.01 | -$0.02 | ? | -$0.01 |
| 2025Q3 | $0.01 | -$0.02 | -$0.01 | -$0.01 |
MEOBF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | ? | ? |
| 2026Q2 | ? | ? |
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -12.83 |
| 2025Q3 | ? | -14.38 |
MEOBF
Price: $1.55
52 week price:
Earnings Per Share: -0.07 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.2 billion